Fulgent Genetics Shares Outstanding 2015-2024 | FLGT
Fulgent Genetics shares outstanding from 2015 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Fulgent Genetics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 30 |
| 2023 | 30 |
| 2022 | 31 |
| 2021 | 31 |
| 2020 | 24 |
| 2019 | 19 |
| 2018 | 18 |
| 2017 | 18 |
| 2016 | 14 |
| 2015 | 12 |
| 2014 | |
| Fulgent Genetics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-12-31 | 30 |
| 2024-09-30 | 30 |
| 2024-06-30 | 30 |
| 2024-03-31 | 30 |
| 2023-12-31 | 30 |
| 2023-09-30 | 30 |
| 2023-06-30 | 30 |
| 2023-03-31 | 30 |
| 2022-12-31 | 31 |
| 2022-09-30 | 31 |
| 2022-06-30 | 31 |
| 2022-03-31 | 31 |
| 2021-12-31 | 31 |
| 2021-09-30 | 31 |
| 2021-06-30 | 31 |
| 2021-03-31 | 31 |
| 2020-12-31 | 24 |
| 2020-09-30 | 24 |
| 2020-06-30 | 23 |
| 2020-03-31 | 22 |
| 2019-12-31 | 19 |
| 2019-09-30 | 19 |
| 2019-06-30 | 19 |
| 2019-03-31 | 18 |
| 2018-12-31 | 18 |
| 2018-09-30 | 18 |
| 2018-06-30 | 18 |
| 2018-03-31 | 18 |
| 2017-12-31 | 18 |
| 2017-09-30 | 18 |
| 2017-06-30 | 18 |
| 2017-03-31 | 18 |
| 2016-12-31 | 14 |
| 2016-09-30 | 13 |
| 2016-06-30 | 12 |
| 2016-03-31 | 12 |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.522B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.685B | 52.05 |
| Tempus AI (TEM) | United States | $8.308B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.565B | 105.54 |
| Inspire Medical Systems (INSP) | United States | $4.740B | 92.07 |
| IRhythm Technologies (IRTC) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.706B | 204.09 |
| Enovis (ENOV) | United States | $2.177B | 13.50 |
| Clover Health Investments (CLOV) | United States | $1.834B | 0.00 |
| Omnicell (OMCL) | United States | $1.635B | 35.31 |
| Azenta (AZTA) | United States | $1.583B | 73.70 |
| Phreesia (PHR) | United States | $1.502B | 0.00 |
| Schrodinger (SDGR) | United States | $1.442B | 0.00 |
| 10x Genomics (TXG) | United States | $1.068B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.554B | 0.00 |
| Veradigm (MDRX) | United States | $0.469B | 0.00 |
| Talkspace (TALK) | United States | $0.431B | 256.00 |
| TruBridge (TBRG) | United States | $0.411B | 0.00 |
| Standard BioTools (LAB) | United States | $0.409B | 0.00 |
| Claritev (CTEV) | United States | $0.334B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.238B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.221B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.067B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| CareCloud (CCLD) | United States | $0.059B | 2.53 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |